Clinical neuropharmacology · 2010
Quetiapine-induced hyperventilation and dyspnea.
Клинический случайСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mutschler Jochen, Obermann Caitriona, Grosshans Martin
Аннотация
OBJECTIVES: Quetiapine is an atypical antipsychotic with favorable properties in the treatment of bipolar disorder, but it has recently been associated with respiratory dysfunction.
METHODS: In this case report, we describe a patient who developed quetiapine-induced hyperventilation and dyspnea after being treated with quetiapine.
RESULTS: To our knowledge, this is the first case presented with quetiapine-induced hyperventilation in a patient with bipolar disorder.
CONCLUSIONS: We recommend a quick reduction of the quetiapine dosage and a change to an alternative antipsychotic for patients treated with quetiapine, who report such respiratory symptoms without a somatic cause for the symptoms.
METHODS: In this case report, we describe a patient who developed quetiapine-induced hyperventilation and dyspnea after being treated with quetiapine.
RESULTS: To our knowledge, this is the first case presented with quetiapine-induced hyperventilation in a patient with bipolar disorder.
CONCLUSIONS: We recommend a quick reduction of the quetiapine dosage and a change to an alternative antipsychotic for patients treated with quetiapine, who report such respiratory symptoms without a somatic cause for the symptoms.